NPRL2 and neoplasm: Resistance to cisplatin has been initially observed in yeast S. cerevisiae for Npr2 and Npr3 deletion mutants [83] (NPRL2 and NPRL3 homologs, respectively), years before GATOR1 components were suggested to be tumor suppressors [18, 20].